325 related articles for article (PubMed ID: 192894)
1. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda.
Geser A; Lenoir GM; Anvret M; Bornkamm G; Klein G; Williams EH; Wright DH; De-The G
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1393-404. PubMed ID: 6315443
[TBL] [Abstract][Full Text] [Related]
3. Analysis of African Burkitt's and high-grade B cell non-Burkitt's lymphoma for Epstein-Barr virus genomes using in situ hybridization.
Prevot S; Hamilton-Dutoit S; Audouin J; Walter P; Pallesen G; Diebold J
Br J Haematol; 1992 Jan; 80(1):27-32. PubMed ID: 1311194
[TBL] [Abstract][Full Text] [Related]
4. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
5. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma.
Geser A; de Thé G; Lenoir G; Day NE; Williams EH
Int J Cancer; 1982 Apr; 29(4):397-400. PubMed ID: 6282763
[TBL] [Abstract][Full Text] [Related]
6. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
7. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlations.
Mansoor A; Stevenson MS; Li RZ; Frekko K; Weiss W; Ahmad M; Khan AH; Mushtaq S; Saleem M; Raffeld M; Kingma DW; Jaffe ES
Hum Pathol; 1997 Mar; 28(3):283-8. PubMed ID: 9042791
[TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma.
Ziegler JL; AnderssonM ; Klein G; Henle W
Int J Cancer; 1976 Jun; 17(6):701-6. PubMed ID: 181331
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
11. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
13. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas.
Wutzler P; Färber I; Sauerbrei A; Helbig B; Wutke K; Rüdiger KD; Scheibner K; Brichàcek B; Vonka V
Oncology; 1986; 43(4):224-9. PubMed ID: 2425318
[TBL] [Abstract][Full Text] [Related]
16. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
Pizzo PA; Chattopadhyay SK; Magrath IT; Del Giacco E; Sherrick D; Gray T
Cancer Res; 1981 Aug; 41(8):3165-71. PubMed ID: 6265077
[TBL] [Abstract][Full Text] [Related]
17. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
Borisch-Chappuis B; Nezelof C; Müller H; Müller-Hermelink HK
Am J Pathol; 1990 Apr; 136(4):751-8. PubMed ID: 1691592
[TBL] [Abstract][Full Text] [Related]
18. Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique.
Luka J; Klein G; Henle W; Henle G
Cancer Lett; 1978 Apr; 4(4):199-205. PubMed ID: 206349
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of Epstein-Barr viral DNA in paraffin-embedded tissues of Burkitt's lymphoma from Argentina using the polymerase chain reaction and in situ hybridization.
Drut RM; Day S; Drut R; Meisner L
Pediatr Pathol; 1994; 14(1):101-9. PubMed ID: 8159607
[TBL] [Abstract][Full Text] [Related]
20. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
Clements GB; Klein G; Povey S
Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
